Literature DB >> 28214373

Improved detection of Zika virus RNA in human and animal specimens by a novel, highly sensitive and specific real-time RT-PCR assay targeting the 5'-untranslated region of Zika virus.

Jasper Fuk-Woo Chan1,2,3,4, Cyril Chik-Yan Yip2, Kah-Meng Tee2, Zheng Zhu2, Jessica Oi-Ling Tsang2, Kenn Ka-Heng Chik2, Terance Gi-Wai Tsang2, Chris Chung-Sing Chan2, Vincent Kwok-Man Poon2, Siddharth Sridhar2, Feifei Yin5, Ivan Fan-Ngai Hung3,6, Sandy Ka-Yee Chau7, Anna Jinxia Zhang2, Kwok-Hung Chan2, Kwok-Yung Yuen1,2,3,4,8.   

Abstract

OBJECTIVE AND
METHOD: We developed and evaluated five novel real-time RT-PCR assays targeting conserved regions in the 5'-untranslated region (5'-UTR), envelope (E'), non-structural protein 2A (NS2A), NS5 and 3'-UTR of the ZIKV genome.
RESULTS: The ZIKV-5'-UTR assay exhibited the lowest in vitro limit of detection (5-10 RNA copies/reaction and 3.0 × 10-1 plaque-forming units/ml). Compared to the modified version of a widely adopted RT-PCR assay targeting the ZIKV-E gene, the ZIKV-5'-UTR assay showed better sensitivity in human clinical specimens, and representative mouse specimens, including many organs which are known to be involved in human ZIKV infection but difficult to obtain in clinical settings. The ZIKV-5'-UTR assay detected ZIKV RNA in 84/84 (100.0%) ZIKV-E'-positive and an additional 30/296 (10.1%, P < 0.01) ZIKV-E'-negative mouse specimens. The higher sensitivity of the ZIKV-5'-UTR assay was most significant in kidney and testis/epididymis specimens (P < 0.01). No in vitro or in vivo cross-reactivity was found between the ZIKV-5'-UTR assay and dengue virus, yellow fever virus, Japanese encephalitis virus, West Nile virus, hepatitis C virus and Chikungunya virus.
CONCLUSIONS: The highly sensitive and specific ZIKV-5'-UTR assay may help to improve the laboratory diagnosis of ZIKV infection.
© 2017 John Wiley & Sons Ltd.

Entities:  

Keywords:  zzm321990PCRzzm321990; Zika; diagnostics; diagnóstico; flavivirus; non traduit; polymerase chain reaction; sin transcribir; untranslated; virus

Mesh:

Substances:

Year:  2017        PMID: 28214373     DOI: 10.1111/tmi.12857

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  14 in total

Review 1.  [Zika virus infection and the nervous system].

Authors:  I W Husstedt; M Maschke; C Eggers; E Neuen-Jacob; G Arendt
Journal:  Nervenarzt       Date:  2018-02       Impact factor: 1.214

2.  STAT2-dependent restriction of Zika virus by human macrophages but not dendritic cells.

Authors:  Dong Yang; Hin Chu; Gang Lu; Huiping Shuai; Yixin Wang; Yuxin Hou; Xi Zhang; Xiner Huang; Bingjie Hu; Yue Chai; Terrence Tsz-Tai Yuen; Xiaoyu Zhao; Andrew Chak-Yiu Lee; Ziwei Ye; Cun Li; Kenn Ka-Heng Chik; Anna Jinxia Zhang; Jie Zhou; Shuofeng Yuan; Jasper Fuk-Woo Chan
Journal:  Emerg Microbes Infect       Date:  2021-12       Impact factor: 7.163

Review 3.  Advances in Diagnosis, Surveillance, and Monitoring of Zika Virus: An Update.

Authors:  Raj K Singh; Kuldeep Dhama; Kumaragurubaran Karthik; Ruchi Tiwari; Rekha Khandia; Ashok Munjal; Hafiz M N Iqbal; Yashpal S Malik; Rubén Bueno-Marí
Journal:  Front Microbiol       Date:  2018-01-19       Impact factor: 5.640

Review 4.  Zika virus infection and implications for kidney disease.

Authors:  Donald J Alcendor
Journal:  J Mol Med (Berl)       Date:  2018-08-31       Impact factor: 4.599

5.  Identification of Broad-Spectrum Antiviral Compounds by Targeting Viral Entry.

Authors:  Michela Mazzon; Ana Maria Ortega-Prieto; Douglas Imrie; Christin Luft; Lena Hess; Stephanie Czieso; Joe Grove; Jessica Katy Skelton; Laura Farleigh; Joachim J Bugert; Edward Wright; Nigel Temperton; Richard Angell; Sally Oxenford; Michael Jacobs; Robin Ketteler; Marcus Dorner; Mark Marsh
Journal:  Viruses       Date:  2019-02-20       Impact factor: 5.048

6.  Simultaneous Coinfection of Macaques with Zika and Dengue Viruses Does not Enhance Acute Plasma Viremia but Leads to Activation of Monocyte Subsets and Biphasic Release of Pro-inflammatory Cytokines.

Authors:  William G Valiant; Mary J Mattapallil; Stephen Higgs; Yan-Jang S Huang; Dana L Vanlandingham; Mark G Lewis; Joseph J Mattapallil
Journal:  Sci Rep       Date:  2019-05-27       Impact factor: 4.379

7.  AHR is a Zika virus host factor and a candidate target for antiviral therapy.

Authors:  Jean Pierre Schatzmann Peron; Cybele C Garcia; Francisco J Quintana; Federico Giovannoni; Irene Bosch; Carolina Manganeli Polonio; María F Torti; Michael A Wheeler; Zhaorong Li; Leonardo Romorini; María S Rodriguez Varela; Veit Rothhammer; Andreia Barroso; Emily C Tjon; Liliana M Sanmarco; Maisa C Takenaka; Seyed Mohamad Sadegh Modaresi; Cristina Gutiérrez-Vázquez; Nágela Ghabdan Zanluqui; Nilton Barreto Dos Santos; Carolina Demarchi Munhoz; Zhongyan Wang; Elsa B Damonte; David Sherr; Lee Gehrke
Journal:  Nat Neurosci       Date:  2020-07-20       Impact factor: 24.884

8.  Non-Invasive versus Invasive Samples for Zika Virus Surveillance: A Comparative Study in New Caledonia and French Guiana in 2015-2016.

Authors:  Marie-Alice Fraiture; Wim Coucke; Morgane Pol; Dominique Rousset; Ann-Claire Gourinat; Antoine Biron; Sylvia Broeders; Els Vandermassen; Myrielle Dupont-Rouzeyrol; Nancy H C Roosens
Journal:  Microorganisms       Date:  2021-06-16

9.  T cell immunity to Zika virus targets immunodominant epitopes that show cross-reactivity with other Flaviviruses.

Authors:  C J Reynolds; O M Suleyman; A M Ortega-Prieto; J K Skelton; P Bonnesoeur; A Blohm; V Carregaro; J S Silva; E A James; B Maillère; M Dorner; R J Boyton; D M Altmann
Journal:  Sci Rep       Date:  2018-01-12       Impact factor: 4.379

Review 10.  Zika Virus Trafficking and Interactions in the Human Male Reproductive Tract.

Authors:  Lucia Regina Cangussu da Silva
Journal:  Pathogens       Date:  2018-05-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.